Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children.
about
Drugs for preventing malaria in travellersIntermittent preventive treatment for malaria in children living in areas with seasonal transmissionDrugs for preventing malaria in travellersChemoprophylaxis and intermittent treatment for preventing malaria in childrenRandomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.Age-related buildup of humoral immunity against epitopes for rosette formation and agglutination in African areas of malaria endemicity.From Livingstone to ecotourism. What's new in travel medicine?Activities and conformational fitting of 1,4-naphthoquinone derivatives and other cyclic 1,4-diones tested in vitro against Pneumocystis carinii.Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.Antiparasitic agent atovaquoneMalaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens.Molecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia.Atovaquone-proguanil for prophylaxis and treatment of malaria.The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum.Antimalarial drugs: current status and new developments.Atovaquone/proguanil for the prophylaxis and treatment of malaria.Peer-reviewed publication of clinical trials completed for pediatric exclusivityIncidence of malaria among mosquito collectors conducting human landing catches in western Kenya.Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki.Malaria, mefloquine and oil-workers.The practice of travel medicine: guidelines by the Infectious Diseases Society of America.Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines.Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation.Tolerability of antimalaria drugs.Prevention of malaria in children.Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children.Tropical medicine at the University of Tübingen.Summary of recommendations for the prevention of malaria by the Committee to Advise on Tropical Medicine and Travel (CATMAT).
P2860
Q21032525-04BF061C-F9B6-49DD-A274-6F2099147703Q21032527-6AFA5D05-4C09-4015-A796-BDFA10D5A740Q24186690-864679DB-94BA-4481-9E25-7303E6591471Q24243240-25B1BC74-D993-4FB0-8D5D-8FA351C76E7FQ30847884-9DC76F58-A44E-4995-82F4-AFABC7436C3FQ33765361-FC72E1BB-B19B-4ABC-AF83-BBCCFDCD480FQ33830436-ECE85D60-ADE7-4323-BA43-B0FDD27FE4CCQ33982091-CD8218EB-237F-4DF7-868A-FC7F9C2C365AQ34088738-0A3C819B-08FE-4236-916C-9DC0C7EF9200Q34107885-51337ED4-6A08-4A67-AB5D-E7F114A03A62Q34289235-A1B5383B-F545-4054-885A-F5368B3076F9Q35191258-F8F0CA36-B9E7-45B7-B65A-AF6722148092Q35201039-3EF883B1-8360-4209-B799-88D679F11682Q36185602-1F6EA5A4-D2CB-4CEB-98F3-2AB0DE719CB3Q36196479-39C48708-14FD-4889-BD57-B15B4FA53B6FQ36322092-861C2FEC-F0EE-4989-A95A-F22020B5A3C1Q36591926-B2461FB0-177D-411D-85C2-0DDFF1031AAEQ36641794-13A0C1E7-53BC-4A23-87F1-4853B8C48734Q37052790-2EE61833-04A7-4D94-AAD1-95A63D6F985AQ38893657-06DD4F1F-C1FB-4786-9C98-B8B34C982FE0Q39067681-76C30804-50A9-4BDA-856A-8D6F71AC580CQ40571679-7D2A8DE7-5BA3-4D50-9F1A-DC27785E7B42Q41913848-7B6ACE55-2060-497A-9CE3-85217AB5347CQ41925324-DC1783A5-E30F-4048-AD73-659591DA2476Q43952844-F426F5C5-C636-43F3-852C-C35F5FA7D424Q44147117-BBB77E31-2EA8-4C84-B595-603FA43BB324Q44160872-28B17539-8C84-4A9E-9E19-2F9593534F59Q47871895-8042B5E9-1008-436C-BA44-569786BA883EQ47938411-773D7475-DD2B-46CB-9BCC-40F4D4AC4E56Q55037358-BC29B145-C1D6-4E22-807D-BE30B1DA7333
P2860
Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Randomised placebo-controlled ...... laria prophylaxis in children.
@en
Randomised placebo-controlled ...... laria prophylaxis in children.
@nl
type
label
Randomised placebo-controlled ...... laria prophylaxis in children.
@en
Randomised placebo-controlled ...... laria prophylaxis in children.
@nl
prefLabel
Randomised placebo-controlled ...... laria prophylaxis in children.
@en
Randomised placebo-controlled ...... laria prophylaxis in children.
@nl
P2093
P1433
P1476
Randomised placebo-controlled ...... laria prophylaxis in children.
@en
P2093
P304
P356
10.1016/S0140-6736(97)09222-2
P407
P577
1998-03-01T00:00:00Z